BIONOTE Trademark

Trademark Overview


On Monday, May 30, 2022, a trademark application was filed for BIONOTE with the United States Patent and Trademark Office. The USPTO has given the BIONOTE trademark a serial number of 97434042. The federal status of this trademark filing is REGISTERED as of Tuesday, January 30, 2024. This trademark is owned by BIONOTE, INC.. The BIONOTE trademark is filed in the Chemical Products category with the following description:

Protease for scientific or laboratory purposes; protein synthetase for scientific or laboratory purposes; restriction enzyme for scientific or laboratory purposes; enzyme for analyzing nucleic acid for scientific or laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes ; polymerase for nucleic acid amplifications for scientific or laboratory purposes; enzyme for nucleic acid amplifications for scientific or laboratory purposes; enzyme for synthesizing nucleic acid for scientific or laboratory purposes; diagnostic reagents for scientific or research use; enzyme substrates; enzyme stabilizers; antigen biomarkers used as reagents for analyzing protein molecules for scientific or research purposes; hormone biomarkers used as reagents for analyzing protein molecules for scientific or research purposes; recombinant protein for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; plasmid for scientific or laborator...
bionote

General Information


Serial Number97434042
Word MarkBIONOTE
Filing DateMonday, May 30, 2022
Status700 - REGISTERED
Status DateTuesday, January 30, 2024
Registration Number7295476
Registration DateTuesday, January 30, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Pseudo MarkBIO NOTE
Goods and ServicesProtease for scientific or laboratory purposes; protein synthetase for scientific or laboratory purposes; restriction enzyme for scientific or laboratory purposes; enzyme for analyzing nucleic acid for scientific or laboratory purposes; polymerase for nucleic acid for scientific or laboratory purposes ; polymerase for nucleic acid amplifications for scientific or laboratory purposes; enzyme for nucleic acid amplifications for scientific or laboratory purposes; enzyme for synthesizing nucleic acid for scientific or laboratory purposes; diagnostic reagents for scientific or research use; enzyme substrates; enzyme stabilizers; antigen biomarkers used as reagents for analyzing protein molecules for scientific or research purposes; hormone biomarkers used as reagents for analyzing protein molecules for scientific or research purposes; recombinant protein for scientific or laboratory purposes; recombinant nucleic acid for scientific or laboratory purposes; plasmid for scientific or laboratory purposes; nucleic acid for scientific or laboratory purposes; RNA markers used as reagents for analyzing nucleic acid for scientific or laboratory purposes; DNA markers used as reagents for analyzing nucleic acid for scientific or laboratory purposes; preparations consisting of enzyme, buffer, primer set or dNTPs for the analysis of nucleic acid for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting nucleic acid for scientific or laboratory purposes; polypeptides for scientific purposes; nucleic acids for scientific purposes; in vitro diagnostic reagents for scientific purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology ; enzymes for industrial purposes; enzyme for scientific or laboratory purposes; diagnostic preparations for scientific or research use; antibodies for scientific purposes, other than for medical or veterinary use; PCR, namely, polymerase chain reaction reagents for clinical or medical laboratory use; PCR, namely, polymerase chain reaction enzymes for clinical or medical laboratory use; PCR, namely, polymerase chain reaction master mixes for clinical or medical laboratory use; antibody reagent used for the detection of antigens in body fluids, cell and tissue analysis for in vitro diagnostic use; diagnostic test kits comprised of monoclonal antibodies, antigens, buffers, assay components and reagents for scientific or medical laboratory use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, June 26, 2023
Primary Code001
First Use Anywhere DateFriday, January 10, 2020
First Use In Commerce DateFriday, January 10, 2020

Trademark Owner History


Party NameBIONOTE, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 18449
KR

Party NameBIONOTE, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGyeonggi-do 18449
KR

Party NameBIONOTE, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGyeonggi-do 18449
KR

Trademark Events


Event DateEvent Description
Tuesday, January 30, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 30, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, December 23, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 22, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, November 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, November 13, 2023USE AMENDMENT FILED
Saturday, November 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 13, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, September 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 26, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 26, 2023EXAMINER'S AMENDMENT ENTERED
Monday, June 26, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 26, 2023EXAMINERS AMENDMENT E-MAILED
Monday, June 26, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 6, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 6, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 22, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, May 22, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, February 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 27, 2023NON-FINAL ACTION E-MAILED
Monday, February 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, February 22, 2023ASSIGNED TO EXAMINER
Monday, June 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 2, 2022NEW APPLICATION ENTERED